Blog Post

GLOBAL ANDROLOGY FORUM

Publications

Sperm DNA Fragmentation: A New Guideline for Clinicians

February 26, 2024

Article #42: “Sperm DNA Fragmentation: A New Guideline for Clinicians”.

Authors: Ashok Agarwal et al.

World J Men’s Health 2020 Oct 38(4): 412-471

https://doi.org/10.5534/wjmh.200128

CAPSULE

Contributors: Ahmad Motawi, MD, PhD, FECSM (Egypt), and

Charalampos Thomas, MD, MSc, PhD, FECSM (Greece)

Commentary:


Despite the technological advances, conventional semen analysis is still the corner stone of infertile men evaluation, but it has limitations in predicting male fertility potential and the outcome of assisted reproductive technology. A normal semen analysis does not rule out infertility in some patients. About 15% of them have normal results.


Sperm DNA Integrity is crucial for fertilization, embryo development and ART outcomes. Many studies have reported a link between SDF and male infertility. So far not only we do not have a routine assessment of Sperm DNA Fragmentation (SDF) but also it isn’t recommended by professional organizations as standard practice.


This article provides a thorough overview on SDF types and methods of assessment, emphasizing on the impact they have in diagnosis and treatment of male infertility. By using clinical scenarios, the authors provide helpful paradigms of implementation of all the current knowledge, and they concluded by performing a SWOT analysis of SDF testing evaluating 4 parameters: Strength-Weakness-Opportunities and finally Threats in order to understand the advantages and drawbacks for the clinical utility of SDF in specific clinical scenarios regarding male infertility.


SDF could originate from either endogenous or primary mechanisms such as defective maturation and abortive apoptosis occurring within the testis, or by oxidative stress throughout the male reproductive tract, or exogenous clinical and environmental risk factors as obesity, smoking, varicocele via increased intratesticular temperature, environmental pollution, exposure to heavy metals or even electromagnetic waves. Any type of DNA damage can be observed, including loss of base, bases mismatch or modifications, single strand (SSB) or double strand breaks (DSB), which induces SDF thus compromising natural conception or ART outcomes.


Numerous techniques have been described, in order to assess SDF, such as tests that label the broken ends of the DNA strands, as TUNEL, SCSA and SCD. However, these tests cannot tell the difference between single-strand breaks (SSBs) and double-strand breaks (DSBs) in the DNA. The two-tailed Comet assay is the only test that can do that. Another test that is recently developed is the γH2AX test, which specifically detects DSBs in sperm DNA.


So, what test should someone order when male infertility is under investigation? The authors have provided detailed tables, comparing the techniques in terms of pregnancy outcome, clinical cut-offs, sensitivity, and specificity among other parameters. Alongside they offer a list of men/couples who will benefit the most from an SDF testing, including men with varicocele, couples with recurrent pregnancy loss, idiopathic and unexplained male infertility, or high-risk patients among others. They also provide suggestions in management of men with high SDF, including oral antioxidants, infections treatment, varicocelectomy, life-style changes, short ejaculatory abstinence, methods of sperm processing and preparation and even the use of testicular sperm for ICSI in some cases.

The authors gave an example of 4 clinical cases that visualize the whole concept, where they provide clinical paradigms of diagnostic workflow and treatment methods.


Finally, the study provided expert recommendations on SDF assessment with SWOT analysis on the clinical utility of sperm SDF testing in specific male infertility scenarios.

1. Strengths:

  • SDF testing can be a valuable additive in specific clinical scenarios, such as inability of natural conception, idiopathic infertility, varicocele, RPL, ART failure and exposition to lifestyle/environmental risk factors.
  • Interventions such as recurrent ejaculation, oral antioxidants, varicocelectomy in clinical varicocele, treatment of GU infections, advanced sperm selection techniques for ICSI or using testicular sperm have been proved efficient in alleviating high SDF in clinical practice in terms of improving fertility.


2. Weaknesses:

  • By far, the greatest limitation is the lack of a definitive cut-off value above which a sample is considered anomalous.
  • Lack of strong recommendation upon the use of SDF in everyday practice.


3. Opportunities:

  • The authors have highlighted the need for further, well designed studies to enhance our understanding of the clinical use of SDF.


4. Threats:

  • International societies such as EAU and AUA do not recommend SDF testing as a routine for the evaluation of male infertility due to lack of sufficient high-quality evidence supporting data.
  • However, emerging data from upcoming research will probably provide sufficient data for the justification of performing SDF testing as routine.
  • SDF cost has to be considered, since it may not be reimbursed by health systems around the globe. However, what may the cost be, please take into consideration how useful it may be in terms of improving the outcome of treatment and the impact on the overall treatment cost.



Take Home Message: (contributor: Ashok Agarwal)

  1. Sperm DNA integrity is critical for successful fertilization and the development of healthy offspring. Damage to sperm DNA can significantly impact both natural and assisted reproductive outcomes.
  2. Various clinical and environmental factors can negatively affect sperm DNA integrity, including lifestyle choices and exposure to toxins, underscoring the importance of a comprehensive evaluation of male fertility beyond traditional semen analysis.
  3. The article underscores the utility of SDF testing in certain clinical scenarios, such as unexplained infertility, recurrent pregnancy loss, and prior to assisted reproductive techniques, to better inform treatment strategies and improve outcomes.
  4. Despite the availability of several assays for assessing sperm DNA damage, there is a lack of consensus on standard cut-off values for predicting reproductive outcomes, highlighting the need for further research and standardized guidelines.
  5. The article emphasizes a multidisciplinary approach to the management of male infertility, incorporating SDF testing alongside other diagnostic tools to tailor interventions more effectively and improve the chances of achieving pregnancy.

My Personal Viewpoint on Diagnostic Value of Advanced Semen Analysis

Dr. Ahmed Motawi responds to questions by Ashok Agarwal


1. What is your personal philosophy on the use of SDF testing for male infertility?


Dr. Motawi: I believe that SDF testing would have more potential in the future in assessing male infertility, but for the time being I am not using it routinely for all patients. I reserve its use for selected case scenarios giving into consideration the lack of a gold standard technique and universally agreed upon cut-off value, in addition to the high cost and lack of well-trained technicians.


2. What are the common indications for ordering this test?


Dr. Motawi: I usually order SDF testing in a selected group of patients mainly idiopathic male infertility, recurrent pregnancy loss with normal female factor, repeated ART failure, presence of chronic reproductive tract infections and for the decision of varicocelectomy in patients with repeated normal semen analyses.


3. What is your preferred SDF test and why?


Dr. Motawi: My preferred SDF test is the halo test being simple to use, most widely available in labs, relatively low cost, about 75 USD in Egypt compared to other tests. However, if available and the patient can afford, I’ll use the two tailed TUNEL test as its more accurate and can differentiate between SS and DS breaks.


4. What is the approximate cost of this test in your country?


Dr. Motawi: Approximately 75-100 USD.


5. Are the results of SDF test of use in the clinical management of your patients?


Dr. Motawi: Yes, as mentioned above, in selected cases the decision to perform varicocelectomy in patients with normal semen analyses depends on SDF test results, the decision to go directly with ART or to wait and use antioxidants treatment first. Also, in resistant high SDF cases with repeated ICSI failure, I may opt to use testicular sperm.

Ahmad Motawi, MBBCH, MSc., MD, FECSM: Short Biography

Ahmad Motawi MD

Associate Professor,

Department of Andrology, Sexual medicine and STIs

Faculty of Medicine

Cairo University, Egypt

E-mail: a7madmotaw3@gmail.com

ORCID ID: https://orcid.org/0000-0003-0962-0604

Ahmed Tareq Motawi, MD is a Consultant Andrologist and Genital Surgeon in the Faculty of Medicine at Cairo University, Egypt. Member of European Academy of Andrology (EAA), International society for Sexual Medicine (ISSM), Middle East society for Sexual Medicine (MESSM), Egyptian Society of Andrology (ESA). He is an academician at the Faculty of Medicine, Cairo University and is currently working as an Associate Professor at the Department of Andrology, Sexual medicine and STIs. He is the Leader of research team 6 in the Global Andrology Forum. Dr. Motawi has a publication count of 8, citation count of 45, and h-index of 3 (source: Web of science)

My Personal Viewpoint on Diagnostic Value of Advanced Semen Analysis

Dr. Charalampos G. Thomas responds to questions by Ashok Agarwal


Q1. What is your personal philosophy on the use of SDF testing for male infertility?


Dr. Thomas: Extremely useful in diagnosing and treating male infertility.


Q2. What are the common indications for ordering this test?


Dr. Thomas: Azo-oligospermia, varicocele, repeated miscarriages, male infertility.


Q3. What is your preferred SDF test and why?


Dr. Thomas: Flow cytometry (more accurate) and HALO (good enough).


Q4. What is the approximate cost of this test in your country?


Dr. Thomas: 150-180 euros and 120 euros respectively


Q5. Are the results of SDF test of use in the clinical management of your patients?



Dr. Thomas: By all means!

Charalampos G. Thomas, MD, MSc, PhD, FECSM: Short Biography

Charalampos G. Thomas, MD

Consultant in Urology & Sexual Medicine

Head of Urology and Neuro-urology Unit, National Rehabilitation Center

General Hospital of Corinth

Athens, Greece

Email: babisthomas@yahoo.gr

ORCID id: https://orcid.org/0000-0003-0139-2221

Charalampos G. Thomas, MD is a urologist with a special interest in Sexual Medicine and functional urology. He is a consultant urologist in Corinth's General Hospital, where he runs both the department of Sexual Medicine & Reproduction and functional urology. He is also a Staff Member in Urology in the General Hospital "Asklepieio Voulas", Vasileos Paulou, in Athens. He is the treasurer of the Hellenic Urological Association (H.U.A) and the secretary of its section of Urodynamics Neurourology and Female Urology. He has also served as secretary of the Andrology and Infertility section of Hellenic Urological Association (HUA). Fellow of the European Board of Urology, Fellow of the European Committee of Sexual Medicine, Member of the Neurourology Promotion Committee of the International Continence Society (ICS), Board Member of the EAU Section of Functional Urology (ESFU), Associate Member of the EAU Section of Genitourinary Reconstructive Surgeons (ESGURS). Associate Member of the EAU Section of Andrological Urology (ESAU).

Share by: